The global Biobanking market was valued at USD 81.42 billion in 2024 and is expected to reach USD 130.75 billion by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.10 % primarily driven by the increased demand for personalized medicine and advancements in genomics and biotechnology. The global biobanking market has emerged as one of the most...